Cargando…
Mixing and administration times of bypassing agents: observations from the Dosing Observational Study in Hemophilia (DOSE)
DOSE (Dosing Observational Study in Hemophilia) was a prospective, observational diary study designed to evaluate the use of bypassing agents in patients prescribed recombinant activated factor VII (rFVIIa) as first-line treatment in the home setting. Patients with congenital hemophilia with inhibit...
Autores principales: | Maahs, Jennifer, Donkin, Jennifer, Recht, Michael, Cooper, David L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149444/ https://www.ncbi.nlm.nih.gov/pubmed/25187744 http://dx.doi.org/10.2147/JBM.S61859 |
Ejemplares similares
-
Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)
por: Young, Guy, et al.
Publicado: (2012) -
The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors
por: Ju, Hee Young, et al.
Publicado: (2015) -
The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study
por: Schultz, Nina Haagenrud, et al.
Publicado: (2021) -
Combining Low-Dose Rituximab and Bortezomib as Immunosuppressive Therapy for Acquired Hemophilia A: 6 Case Series
por: Fu, Yuhan, et al.
Publicado: (2023) -
Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents
por: Saito, Makoto, et al.
Publicado: (2018)